subject_id=OCCAMS/AH/088;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/033;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/086;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/088;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/140;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/033;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/122;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/122;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/173;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/122;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/122;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/122;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/173;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/173;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/173;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/020;gender=female;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/020;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/075;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/088;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/134;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/121;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/121;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/121;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/075;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/075;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=P03;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=P03;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/075;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/075;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/075;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/075;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/075;gender=male;phenotype=tumor, pleura;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/075;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=P03;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=P03;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=P03;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=P03;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=P03;gender=male;phenotype=tumor, liver;ENA-CHECKLIST=ERC000026;
subject_id=PO5;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=PO5;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=PO5;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=PO7;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=PO7;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=PO7;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=PO4;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=PO4;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=PO7;gender=male;phenotype=barrett's;ENA-CHECKLIST=ERC000026;
subject_id=PO5;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=PO5;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=PO5;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=PO5;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=PO5;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
subject_id=PO5;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
subject_id=PO5;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
subject_id=PO7;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=PO7;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=PO7;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=PO7;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=PO7;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
subject_id=PO7;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
subject_id=PO4;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=PO4;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=PO4;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=PO4;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=PO4;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
subject_id=P09 DM1;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
subject_id=P09 LN1;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=P09 LN2;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
subject_id=P09 LN3;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor, lymph node;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/271;subject_id=OC/AH/271;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/122;subject_id=OC/AH/122;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/122;subject_id=OC/AH/122;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/140;subject_id=OC/AH/140;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/140;subject_id=OC/AH/140;gender=male;phenotype=tumor, metastasis;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=P10;subject_id=P10;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/AH/284;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=PO6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=PO6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=PO6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=PO6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=PO6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=PO8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=PO8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=PO8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=PO8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, lymph node;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, lymph node;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, lymph node;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, lymph node;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, lymph node;subject_id=OCCAMS/AH/284;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, lymph node;subject_id=PO6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, lymph node;subject_id=PO6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, metastasis;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, metastasis;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, metastasis;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, metastasis;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, metastasis;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, metastasis;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, metastasis;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor, metastasis;subject_id=P11;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=P09 T1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=P09 T2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=P09 T3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=P09 T4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=P10;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/086;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
